Stocks
Rafael Holdings, Inc.RFL
NYSEHealthcareBiotechnology$1.31
Price as of · delayed, not real-time
A holding company with interests in real estate and investments, primarily known for its controlling stake in a clinical-stage oncology drug developer. Investors track RFL for its exposure to early-stage cancer therapeutics and its historical connection to the organi family. Its main operating asset is a clinical-stage biopharmaceutical unit focusing on novel cancer treatments.
52W Range: $1.12-$3.96
Congressional Interest in Rafael Holdings, Inc. (RFL)
No congressional trades have been disclosed for Rafael Holdings, Inc. (RFL) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading RFL?
No congressional trades found for this stock.